Jul. 15 at 10:19 PM
$MCK
Trading 15% below the analyst consensus target of
$940.73 and at a P/E of 19.8 versus a sector average of 25.1 — MCK is cheap relative to its peers for no fundamental reason that holds up under scrutiny.
Five-year return of 324.7% tells you what this business does over time. The earlier revenue miss that knocked the stock was a misread — EPS growth remained strong, the buyback is running, and the healthcare distribution thesis is intact.
Watching for a clean technical setup.
